Search

Showing "11154" results for ""

No specific mention of AIDS in Mbeki speech as Mandela refuses to endorse TAC demo

Male domination of women hinders HIV prevention

New erectile dysfunction drug has interaction with HIV protease inhibitors

Early lipid increases on HAART represent return to normal level for age group

HIV-positive gay men on HAART no more likely to have unprotected sex than untreated men

Brown tells drug companies to face up to international HIV responsibilities in Guardian interview

Spotlight on antibodies in Boston HIV vaccine sessions

More South African companies provide anti-HIV drugs and condoms

New kind of AIDS vaccine, new kind of trial?

Tipranavir shows activity for PI-resistant patients

VaxGen pledges continued efforts for an AIDS vaccine

HIV vaccine fails in first large trial; may protect Blacks, Asians only

T-20 to sell at 18,980 euros: most expensive HIV drug yet

Studies provide more information on HIV, HAART and heart disease

Tenofovir approved for first-line therapy in European Union

More scepticism than enthusiasm for VaxGen claims on race and AIDS vaccine response

US study finds poor adherence, depression, drug use and unprotected sex linked

Nevirapine studied as pre-exposure prophylaxis for HIV: safe in 200 mg dose

Receive the latest HIV research and conference news

Showing "11154" results for ""

No specific mention of AIDS in Mbeki speech as Mandela refuses to endorse TAC demo

Male domination of women hinders HIV prevention

New erectile dysfunction drug has interaction with HIV protease inhibitors

Early lipid increases on HAART represent return to normal level for age group

HIV-positive gay men on HAART no more likely to have unprotected sex than untreated men

Brown tells drug companies to face up to international HIV responsibilities in Guardian interview

Spotlight on antibodies in Boston HIV vaccine sessions

More South African companies provide anti-HIV drugs and condoms

New kind of AIDS vaccine, new kind of trial?

Tipranavir shows activity for PI-resistant patients

VaxGen pledges continued efforts for an AIDS vaccine

HIV vaccine fails in first large trial; may protect Blacks, Asians only

T-20 to sell at 18,980 euros: most expensive HIV drug yet

Studies provide more information on HIV, HAART and heart disease

Tenofovir approved for first-line therapy in European Union

More scepticism than enthusiasm for VaxGen claims on race and AIDS vaccine response

US study finds poor adherence, depression, drug use and unprotected sex linked

Nevirapine studied as pre-exposure prophylaxis for HIV: safe in 200 mg dose

Receive the latest HIV research and conference news